Raymond Pigeon MD in San Diego, California

Medical School: University Of Pittsburgh School Of Medicine
Graduation Year: 1995
The Primary Medical Specialty for Raymond Pigeon MD is listed as: Internal Medicine
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 29
PAC (PECOS ID)#: 7911989298
NPI #: 1366404923
NPI Created On: 04/06/2006
NPI Last Updated Listed as: 06/08/2012
Primary Taxonomy Code: 207R00000X
License Number:
A62257
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Stool analysis for blood to screen for colon tumors
2. Vaccine for influenza for injection into muscle
3. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
4. Routine ekg using at least 12 leads including interpretation and report
5. Established patient office or other outpatient visit, typically 15 minutes
6. Established patient office or other outpatient, visit typically 25 minutes
7. Initial hospital inpatient care, typically 50 minutes per day
8. Initial hospital inpatient care, typically 70 minutes per day
9. Subsequent hospital inpatient care, typically 25 minutes per day
10. Subsequent hospital inpatient care, typically 35 minutes per day
11. Hospital discharge day management, 30 minutes or less
12. Hospital discharge day management, more than 30 minutes
13. Administration of influenza virus vaccine
14. Administration of pneumococcal vaccine
15. Prostate cancer screening; digital rectal examination
16. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.